Harrow Health Inc HROWM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EST
25.14UNCH (UNCH)
Volume
64,781
52 week range
24.40 - 25.45
Loading...
  • Open25.10
  • Day High25.32
  • Day Low25.05
  • Prev Close25.14
  • 52 Week High25.45
  • 52 Week High Date12/21/22
  • 52 Week Low24.40
  • 52 Week Low Date12/21/22

Key Stats

  • Market Cap398.8M
  • Shares Out27.07M
  • 10 Day Average Volume0.02M
  • Dividend1.35
  • Dividend Yield5.38%
  • Beta-
  • YTD % Change0.24

KEY STATS

  • Open25.10
  • Day High25.32
  • Day Low25.05
  • Prev Close25.14
  • 52 Week High25.45
  • 52 Week High Date12/21/22
  • 52 Week Low24.40
  • 52 Week Low Date12/21/22
  • Market Cap398.8M
  • Shares Out27.07M
  • 10 Day Average Volume0.02M
  • Dividend1.35
  • Dividend Yield5.38%
  • Beta-
  • YTD % Change0.24

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date01/12/2023
  • Div Amount0.3381
  • Split Date-
  • Split Factor-

Latest On Harrow Health Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Harrow Health, Inc. is an eyecare pharmaceutical company. The Company serves ophthalmologists and optometrists by providing branded ophthalmic pharmaceuticals and compounded prescription medicines. The Company's business specializes in the development, production and sale of medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. Its five branded ophthalmic products include ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE....
Mark Baum J.D.
Chairman of the Board, Chief Executive Officer
Andrew Boll
Chief Financial Officer, Corporate Secretary
Address
102 WOODMONT BLVD, SUITE 610
Nashville, TN
37215
United States